Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs Summit Therapeutics Inc (SMMT) Price & Performance

Humana IncTrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs Summit Therapeutics Inc — how do they compare? Humana Inc trades at $372.16 (market cap $44.77B), while Summit Therapeutics Inc trades at $15.34 (market cap $12.06B). The key difference: Humana Inc is far larger — about 3.7× Summit Therapeutics Inc's market cap, and Humana Inc pays a 0.95% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.

HUMSMMT
Market Cap
$44.77B$12.06B
Sector
HealthHealth
52-Week High
$409.42$26.98
52-Week Low
$163.67$12.55
Enterprise Value
$52.12B$11.39B
Dividend Yield
0.95%

Returns comparison

Trailing returns across standard periods

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT